share_log

智飞生物:关于26价肺炎球菌结合疫苗进入Ⅰ/Ⅱ期临床试验的公告

Chongqing Zhifei Biological Products: Announcement regarding the entry of the 26-valent pneumococcal conjugate vaccine into phase I/II clinical trials.

SZSI ·  Aug 20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more